| Phase 3 |
| NCT06711900 |
A Study of SKB264 in Combination With Pembrolizumab Versus Chemotherapy in Combination… |
Non-Small Cell Lung Cancer |
Recruiting |
| NCT06081959 |
Study of SKB264 for Locally Advanced, Recurrent or Metastatic HR+/HER2- Breast Cancer |
Metastatic Breast Cancer |
Recruiting |
| NCT06279364 |
A Study of SKB264 Versus Investigator's Choice Chemotherapy in Patients With Unresectable… |
Triple Negative Breast Cancer |
Recruiting |
| NCT06670196 |
A Study of SKB264 in Combination With Osimertinib Versus Osimertinib in Patients With… |
Non-Small Cell Lung Cancer |
Recruiting |
| NCT07071337 |
A Study of SKB264 Versus Investigator's Choice of Chemotherapy in Subjects With… |
Metastatic Breast Cancer |
Recruiting |
| NCT05294172 |
KL-A167 Injection Combined With Cisplatin and Gemcitabine vs Placebo Combined With… |
Nasopharyngeal Carcinoma |
Active, Not Recruiting |
| NCT05347134 |
SKB264 Injection vs Investigator Selected Regimens to Treat Locally Advanced, Recurrent… |
Triple Negative Breast Cancer |
Active, Not Recruiting |
| NCT05870319 |
A Phase III Study of SKB264 for EGFR Mutant NSCLC Patients |
Non-small Cell Lung Cancer |
Active, Not Recruiting |
| NCT06448312 |
A Study of SKB264 in Combination With Pembrolizumab Versus Pembrolizumab in Patients With… |
Non-Small Cell Lung Cancer |
Active, Not Recruiting |
| NCT06968585 |
A Study of A166 Versus Trastuzumab Emtansine (T-DM1) in Patients With HER2-Positive… |
HER2-positive Breast Cancer |
Active, Not Recruiting |
| Phase 2 |
| NCT07019675 |
A Study of SKB518 in Patients With Lung Cancer |
Lung Carcinoma |
Recruiting |
| NCT07296809 |
SKB500 Combinations in Patients With Small Cell Lung Cancer |
Small Cell Lung Cancer |
Recruiting |
| NCT07299825 |
A Study of A166 in Patients With HER2-Positive Unresectable or Metastatic Breast Cancer |
Her 2 Positive Breast Cancer |
Recruiting |
| NCT07308106 |
A Phase II Clinical Study of SKB571 as Monotherapy in Patients With Locally Advanced or… |
Non-small Lung Cancer |
Recruiting |
| NCT07329322 |
Phase II Study of Sacituzumab Tirumotecan in Combination With Osimertinib or Sacituzumab… |
Non-Small Cell Lung Cancer |
Recruiting |
| NCT05351788 |
SKB264 Combinatiton Therapy in Patients With Advanced or Metastatic Non-small Cell Lung… |
Non-small Cell Lung Cancer |
Recruiting |
| NCT07230405 |
A Phase II Study of SKB571 in Patients With Lung Cancer |
Lung Cancer (Non-Small Cell) |
Recruiting |
| NCT07448922 |
A Study of SKB518 as Monotherapy or Combination Therapy in Patients With Advanced… |
Advanced Gynecological Malignancies |
Recruiting |
| NCT07324629 |
Sacituzumab Tirumotecan in Participants With Locally Advanced or Metastatic Thymic… |
Thymic Carcinoma |
Not Yet Recruiting |
| NCT05445908 |
SKB264 +/- KL-A167 in Recurrent or Metastatic HER2-negative Breast Cancer |
Triple-negative Breast Cancer and HR+/HER2- BC |
Active, Not Recruiting |
| NCT05631262 |
SKB264 Monotherapy in Selected Subjects With Advanced Solid Tumors |
Selected Subjects With Advanced Solid Tumors |
Active, Not Recruiting |
| NCT07564466 |
A Study of SKB571 in Participants With Gastrointestinal Tumors |
Gastrointestinal Tumors |
Not Yet Recruiting |
| NCT07609667 |
SKB315 in Combination Therapy in Patients With Advanced or Metastatic GC/ GEJ… |
Gastroesophageal Junction Adenocarcinoma |
Not Yet Recruiting |
| NCT07341100 |
Study to Evaluate the Preliminary Efficacy of SKB264 and the Effect of Clarithromycin on… |
Ovarian Epithelial Cancer |
Active, Not Recruiting |
| NCT07622186 |
A Study of SKB571 Combination Therapy in Participants With Non-Small Cell Lung Cancer… |
Non-Small Cell Lung Cancer |
Not Yet Recruiting |